Collaboratory Products

Speaker Series

Dr. Ryan Kelly, Microdosing: A Guide to Using Buprenorphine During the Illicit Fentanyl Pandemic. September 24, 2021.  PresentationSlides  – Handout

Peer-Reviewed Manuscripts

Brown KW, Carlisle K, Raman SR, Shrader P, Jiao M, Smith MJ, Einhorn LM, Wong CA. Children and the Opioid Epidemic: Age-Stratified Exposures and Harms. Health Affairs, 2020;39(10):1737-42. PMID: 33017234.

Check DK, Bagett CD, Kim K, Roberts AW, Roberts MC, Robinson T, Oeffinger KC, Dinan MA. Predictors of Chronic Opioid Use: A Population-level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims. J Natl Cancer Inst, 2021 Apr 20;djab082. PMID: 33881543

Cunningham DJ, George SZ, Lewis BD. The Impact of State Level Public Policy, Prescriber Education, and Patient Factors on Opioid Prescribing in Elective Orthopedic Surgery: Findings From a Tertiary, Academic Setting. Mayo Clin Proc Inn Qual Out. 2021;5(1):23-3. PMID: 33718781

Op-eds / Commentaries

Robertson A, Larson M. 2020. The pandemic and North Carolinians battling drug addiction. NC Policy Watch. May 4, 2020.

Lentz T, Goertz C, Sharma I, Gonzalez-Smith J, Saunder R. Managing Multiple Irons in the Fire: Continuing to Address the Opioid Crisis and Improve Pain Management during a Public Health Emergency. NEJM Catalyst. June 22, 2020.

Ivey N, Clifton DC. Tales from the frontlines: An alarming rise in hospitalizations related to opioid use disorder in the era of COVID-19. J Opioid Manag. Jan-Feb 2021;17(1):5-7. PMID: 33735422

Carnago L, O’Regan A, Hughes JM. Diagnosing and treating chronic pain: Are we doing this right? J of Prim Care Community Health. 2021 Jan-Dec;12:21501327211008055. PMID: 33882736 PMCID: PMC8072853

Policy Briefs

Brinkley-Rubinstein L, Zaller N. The Provision of Medications for Opioid Use Disorder in Correctional Settings in the Time of COVID-19: Opportunities and Solutions. Foundation for Opioid Response Efforts.

Stakeholder Reports / Case Studies

Chen H, O’Regan A, Des Marais A, Sachdeva N, Gunn A, Kitlas A, Patel A, Smith M, Skinner A. 2020. Qualitative Study of Local Health Department Programs to Prevent Opioid Overdose in North Carolina.

  1. Final Report
  2. Key Recommendations One-Pager
  3. Overdose Prevention Case Studies:

Exemplary Integrated Pain Management Programs Case Studies:


Guthrie S, Harrison L, Chen H, Sachdeva N, Coles T. 2020. HARM NOT - Helping Assess Rural MOUD: Novel Office-based Therapy in a Rural North Carolina Health Department. American Public Health Association Annual Meeting and Expo. Virtual. October 24-28, 2020.

Chen H, Des Marais A, O’Regan A, Sachdeva N, Gunn A, Kitlas A, Patel A, Smith M. Supporting Community Based Efforts to Address the Overdose Crisis through Funding Local Health Departments in North Carolina. 13th Annual Conference on the Science of Dissemination and Implementation in Health (Academy Health). Virtual. December 15-17, 2020. 

Coles T, Chen H, Des Marais A, Bush C, Sachdeva N, Harrison L, Guthrie S. Helping Assess Rural MOUD: Novel Office-based Treatment (HARM NOT). Rx Drug Abuse & Heroin Summit. Virtual. April 5-8, 2021.

Carnago L, Sheffield C, O’Regan A, Puryear S, Poley S, Hughes J. Opioid Prescribing Process and Quality Improvement at Duke University Health System. Rx Drug Abuse & Heroin Summit. Virtual. April 5-8, 2021.

Brinkley-Rubinstein L, Chen H, Sachdeva N. Bringing Medication for Opioid Use Disorder to Individuals Involved in the Criminal Legal System in North Carolina. Rx Drug Abuse & Heroin Summit. Virtual. April 5-8, 2021.

Des Marais A, Sachdeva N, Mathis M, Skinner A. Customizing Data Infrastructure for Syringe Services Programs in North Carolina. Rx Drug Abuse & Heroin Summit. Virtual. April 5-8, 2021.

Chen H, Choi Y, Corneli A, Des Marais A, Perry B, Poley S, Sachdeva N, McKellar M. Providing A Resource: Telemedicine at Needle Exchanges to Reach Underserved People (PARTNER UP). Rx Drug Abuse & Heroin Summit. Virtual. April 5-8, 2021.